Director of the Experimental Therapeutics Program in Cleveland Clinic’s Mellen Center for Multiple Sclerosis, Jeffrey Cohen, MD, shares insights on how stem cell-based therapies may provide revolutionary treatment options for neurological disorders and deliver exciting prospects in modern medicine.
For information about claiming CE credits, go to clevelandclinic.org/neuropodcast and click on the episode.
